All Episodes

January 24, 2024 61 mins

The Medical Revolution of Messenger RNA

By Fabrice Delaye

Foreword by Nobel Prize Winner Thomas Cech

This week on the Rick Flynn Presents podcast: Can you say "Astonishing?"

When mRNA-based vaccines came to the rescue during the pandemic in seemingly record time, our guest Fabrice Delaye realized that their development could not have been as simple and quick as people wanted to believe. But when he tracked down the origins of mRNA technologies, he uncovered a dramatic story that had never been told. Building on decades of research, tacts and his unique grasp of the science and the stakes involved, Delaye interviewed more than fifty mRNA scientists and entrepreneurs worldwide. His book documents the long, harrowing, unlikely but ultimately triumphant road to a discovery with the potential to revolutionize medicine far beyond the pandemic.

Fabrice Delaye is a science and technology journalist based in Switzerland. He was U.S. correspondent at the daily Swiss newspaper L’Agefi, science and technology editor at magazine Bilan, and is now a reporter-at-large for Heidi.news in Geneva. He is a graduate of the Institut d'Études Politiques de Paris and has a master’s degree from the Swiss Institute of Technology in Lausanne, EPFL.

Published by: Cold Spring Harbor Laboratory Press

--- Support this podcast: https://podcasters.spotify.com/pod/show/rick-flynn/support
Mark as Played

Advertise With Us

Popular Podcasts

Dateline NBC
Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

The Nikki Glaser Podcast

The Nikki Glaser Podcast

Every week comedian and infamous roaster Nikki Glaser provides a fun, fast-paced, and brutally honest look into current pop-culture and her own personal life.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2024 iHeartMedia, Inc.